CytomX Therapeutics, Inc. (CTMX)
2.03
-0.02
(-0.98%)
USD |
NASDAQ |
Nov 20, 16:00
2.05
+0.02
(+0.99%)
After-Hours: 20:00
CytomX Therapeutics Total Liabilities (Quarterly) : 79.79M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 79.79M |
| June 30, 2026 | 79.16M |
| March 31, 2026 | 39.41M |
| December 31, 2025 | 53.49M |
| September 30, 2025 | 50.86M |
| June 30, 2025 | 55.15M |
| March 31, 2025 | 73.45M |
| December 31, 2024 | 123.10M |
| September 30, 2024 | 162.43M |
| June 30, 2024 | 190.45M |
| March 31, 2024 | 216.37M |
| December 31, 2023 | 252.60M |
| September 30, 2023 | 272.40M |
| June 30, 2023 | 294.21M |
| March 31, 2023 | 321.27M |
| December 31, 2022 | 350.24M |
| September 30, 2022 | 198.02M |
| June 30, 2022 | 211.38M |
| March 31, 2022 | 228.63M |
| December 31, 2021 | 344.48M |
| September 30, 2021 | 259.56M |
| June 30, 2021 | 271.49M |
| March 31, 2021 | 288.14M |
| December 31, 2020 | 314.40M |
| Date | Value |
|---|---|
| September 30, 2020 | 327.12M |
| June 30, 2020 | 343.65M |
| March 31, 2020 | 366.90M |
| December 31, 2019 | 290.17M |
| September 30, 2019 | 290.44M |
| June 30, 2019 | 303.78M |
| March 31, 2019 | 321.94M |
| December 31, 2018 | 327.36M |
| September 30, 2018 | 325.06M |
| June 30, 2018 | 335.81M |
| March 31, 2018 | 326.82M |
| December 31, 2017 | 328.15M |
| September 30, 2017 | 341.56M |
| June 30, 2017 | 299.62M |
| March 31, 2017 | 104.10M |
| December 31, 2016 | 120.96M |
| September 30, 2016 | 103.46M |
| June 30, 2016 | 105.67M |
| March 31, 2016 | 79.24M |
| December 31, 2015 | 71.55M |
| September 30, 2015 | 71.75M |
| June 30, 2015 | 70.99M |
| March 31, 2015 | 73.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 10.91B |
| Arcturus Therapeutics Holdings, Inc. | 46.59M |
| Corvus Pharmaceuticals, Inc. | 15.56M |
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.68M |
| Shareholders Equity (Quarterly) | 284.89M |
| Debt to Equity Ratio | 0.0154 |
| Current Ratio | 7.820 |
| Net Debt Paydown Yield | 0.08% |